25 completed, 18 terminated, 2 unknown, 1 active not recruiting. 35 Phase 3, 7 Phase 2, 4 Phase 1, 2 Phase 4, 1 Not applicable.
Follow Rimonabant: new trials by email Literature Review of Rimonabant trials Research Report on Rimonabant
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Rimonabant on Hand Function in Patients With Spinal Cord Injury Rimonabant - Cervical Spinal Cord Injury | Phase 1 / Phase 2 | Active not recruiting | Sinfatin S.L | 8 | 2026-05-13 | 2026-10-21 |
| Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury Rimonabant - Spinal Cord Injuries | Phase 2 | Unknown | Hospital Nacional de Parapléjicos de Toledo | 80 | 2022-11-01 | 2022-11-21 |
| Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury Rimonabant - Spinal Cord Injuries | Phase 1 / Phase 2 | Completed | Hospital Nacional de Parapléjicos de Toledo | 8 | 2021-05-12 | 2022-11-15 |
| Antagonistic Interaction CB1-paracetamol Rimonabant and Paracetamol and placebo - Pain | Phase 1 | Completed | University Hospital, Clermont-Ferrand | 24 | 2008-09-01 | 2011-01-19 |
| Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 Diabetes Rimonabant, Metformin, placebo - Diabetes Mellitus, Type 2 | Phase 3 | Withdrawn | Sanofi | 2008-09-01 | 2016-05-17 | |
| Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes Rimonabant, Placebo (for Rimonabant), Metformin - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | Sanofi | 403 | 2008-05-01 | 2016-05-18 |
| Clinical and Neurobiological Effects of Cannabis Dependence in Young Adults rimonabant, placebo - Cannabis Dependence, Cannabis Withdrawal | Phase 2 | Completed | The Scripps Research Institute | 66 | 2008-04-30 | 2017-06-19 |
| Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese Patients rimonabant (SR141716) - Obesity, Weight Loss | Phase 3 | Terminated | Sanofi | 331 | 2008-04-01 | 2009-06-17 |
| Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases. Simvastatin or Atorvastatin, Enalapril, Aspirin or clopidogrel - Atherosclerosis, Cardiovascular Diseases | Phase 4 | Unknown | Hospital Arnau de Vilanova | 2948 | 2008-04-01 | 2008-08-14 |
| An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 Diabetes Rimonabant, Placebo (for Rimonabant) - Fatty Liver | Phase 3 | Terminated | Sanofi | 89 | 2008-02-01 | 2016-05-18 |
| An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without Diabetes Rimonabant, Placebo (for Rimonabant) - Fatty Liver | Phase 3 | Terminated | Sanofi | 165 | 2008-01-01 | 2016-05-18 |
| The Effects of Rimonabant, on Weight and Metabolic Risk Factors Rimonabant, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 2 | Terminated | University of Maryland, Baltimore | 17 | 2007-11-01 | 2019-11-04 |
| REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents Rimonabant, Placebo - Diabetes Mellitus, Type 2 | Phase 3 | Completed | Sanofi | 358 | 2007-10-01 | 2010-12-10 |
| Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome rimonabant, placebo - Prader-willi Syndrome | Phase 3 | Terminated | Weill Medical College of Cornell University | 10 | 2007-08-01 | 2023-03-20 |
| The Effect of Rimonabant on Energy Expenditure, Fat Metabolism and Body Composition rimonabant, Dietary intervention - Obesity | Phase 4 | Terminated | University of Surrey | 14 | 2007-07-01 | 2010-04-19 |
| Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and Exercise Rimonabant, placebo (for Rimonabant), Diet and exercise - Obesity, Diabetes Mellitus Type 2 | Phase 3 | Terminated | Sanofi | 321 | 2007-04-01 | 2016-06-08 |
| Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic Drug Rimonabant, Placebo (for Rimonabant), Anti-diabetic monotherapy - Obesity, Diabetes Mellitus Type 2 | Phase 3 | Terminated | Sanofi | 458 | 2007-04-01 | 2016-06-06 |
| Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk Factors Rimonabant, Placebo - Obesity, Microalbuminuria | Phase 3 | Terminated | Sanofi | 174 | 2007-03-01 | 2010-12-10 |
| A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes Rimonabant, Glimepiride, Metformin - Diabetes Mellitus, Type 2 | Phase 3 | Terminated | Sanofi | 508 | 2007-03-01 | 2016-05-16 |
| Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS) rimonabant (SR141716), placebo - Obesity | Phase 3 | Terminated | Sanofi | 915 | 2007-02-01 | 2009-07-20 |
Showing 20 of 47. Sign in to see all of them.
Obesity (21) · Diabetes Mellitus, Type 2 (11) · Diabetes Mellitus (4) · Dyslipidemias (4) · Smoking Cessation (4) · Metabolic Syndrome (3) · Weight Loss (3) · Cardiovascular Diseases (2) · Carotid Artery Diseases (2) · Fatty Liver (2) · Marijuana Abuse (2) · Spinal Cord Injuries (2) · Stroke (2) · Agnosia (1) · Alcohol Drinking (1)
Sanofi (35) · Hospital Nacional de Parapléjicos de Toledo (2) · Aristotle University Of Thessaloniki (1) · Hospital Arnau de Vilanova (1) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · National Institute on Drug Abuse (NIDA) (1) · Sinfatin S.L (1) · The Scripps Research Institute (1) · University Hospital, Clermont-Ferrand (1) · University of Maryland, Baltimore (1) · University of Surrey (1) · Weill Medical College of Cornell University (1)
United States (27) · Spain (15) · France (14) · United Kingdom (13) · Canada (11) · Finland (11) · Italy (11) · Netherlands (11) · Australia (10) · Sweden (10) · Belgium (8) · Germany (8) · Hungary (8) · Switzerland (8) · Mexico (7)
Antonio Oliviero, MD, PhD (2) · Barbara J Mason, Ph.D. (1) · Christos Liapis, Professor (1) · David L Russell-Jones, MBBS,MD,FRCP (1) · Deepak L. Bhatt, MD (1) · Dubray Claude, Pr (1) · Elvira Fernandez, MD,PhD (1) · Eric Topol, MD (1) · John Blundell, Pr (1) · John JP Kastelein, MD (1)
PMID 15836887, PMID 16291982, PMID 16478899, PMID 17098084, PMID 18387931, PMID 18417461, PMID 19149823, PMID 20709233, PMID 20965292, PMID 20976246, PMID 21610270, PMID 21869692, PMID 22170727, PMID 22445512, PMID 23147209, PMID 24464597, PMID 24768795, PMID 24956535, PMID 25022935, PMID 25077901, PMID 25142320, PMID 25264981, PMID 25453890
2005 (3), 2008 (1), 2025 (1), P20DA024194 (1)